Featured Research Search Results
IGNITE-TX - Identifying Individuals for Genetic Testing for Familial Cancer
Clinicaltrials.gov identifier:
NCT07318363
Prevention
People with a genetic mutation in BRCA1, BRCA2 or Lynch syndrome who have relatives who have not been tested
Phase 3
Virtual Exercise Classes for Adult Cancer Survivors (SURGE)
Clinicaltrials.gov identifier:
NCT07290309
Quality of Life
Exercise study for people diagnosed within the past 5 years
Treating Advanced MSI-High or dMMR Cancers Using the Targeted Therapy MOMA-341 Given Alone or In Combination with Standard Therapies
Clinicaltrials.gov identifier:
NCT06974110
Treatment
Treatment study for people with advanced or metastatic cancers
Phase 1
REKINDLE: Your Ability to Cope With a Life-Changing Medical Diagnosis
Clinicaltrials.gov identifier:
NCT07002034
Quality of Life
Study for those experiencing mental health struggles due to a diagnosis of cancer or other medical illness
Phase 2
A New Drug, DT2216, Combined With Paclitaxel for Recurrent Platinum-Resistant Ovarian Cancer
Clinicaltrials.gov identifier:
NCT06964009
Treatment
Treatment study for people with recurrent platinum-resistant ovarian cancer
Phase 1
Multi-Cancer Detection Blood Tests in Adults Without Cancer: Vanguard Study
Clinicaltrials.gov identifier:
NCT06995898
Prevention
A study testing two multi-cancer detection blood tests in people who do not have cancer
Psilocybin Therapy in Advanced Cancer
Clinicaltrials.gov identifier:
NCT05398484
Quality of Life
Study for people with advanced cancer
Phase 2
Comparing Treatment with Sacituzumab Govitecan and Bevacizumab to Chemotherapy and Bevacizumab for Recurrent Ovarian Cancer After PARP Inhibitor Maintenance Therapy
Clinicaltrials.gov identifier:
NCT07504588
Treatment
Study for platinum-sensitive ovarian cancer that has progressed after PARP inhibitor
Phase 2
A 5-minute Patient and Caregiver survey to share experiences with immunotherapy and any short-term or long-term side effects
Surveys, Registries, Interviews
Survey on immunotherapy to share experiences, including side effects and whether they were resolved or not
Testing the Drug CX-5461 for Treating Metastatic Solid Tumors
Clinicaltrials.gov identifier:
NCT06606990
Treatment
Phase 1 study for treatment of advanced solid tumors
Phase 1
Testing a Targeted Therapy ETX-19477 to Treat Advanced Solid Tumors in People with a BRCA2 Mutation (ERADIC8)
Clinicaltrials.gov identifier:
NCT06395519
Treatment
Treatment study for people with advanced breast, colorectal, endometrial, ovarian or pancreatic cancer
Phase 1/2
Comparing an Investigational Targeted Drug AZD5335 to Standard Treatments in People With Platinum‑Resistant Ovarian Cancer (TREVI‑OC‑01)
Clinicaltrials.gov identifier:
NCT07218809
Treatment
Treatment study for platinum-resistant ovarian cancer
Phase 3
Using a Blood Test to Detect Early Cancer Recurrence After Treatment (ORACLE)
Clinicaltrials.gov identifier:
NCT05059444
Treatment
Post-treatment study to monitor for recurrence
An Early Detection and Prevention Study for People with an Increased Risk of Cancer (InAdvance)
Clinicaltrials.gov identifier:
NCT05463796
Prevention
Study for people at risk of cancer, including previvors, survivors and family members
The EASE Study: Helping People with Advanced Cancer Cope with Fear of Cancer Progression
Clinicaltrials.gov identifier:
NCT07636200
Quality of Life
Quality of life study for people with advanced cancer experiencing anxiety
A Study of Fallopian Tube Removal with Delayed Ovary Removal to Lower Ovarian Cancer Risk (TUBA-WISP-II)
Clinicaltrials.gov identifier:
NCT04294927
Prevention
Prevention study for women at high risk for ovarian cancer
Treating Advanced Breast or Other Solid Cancers Using a Combination of a New Targeted Therapy, ZEN003694, With The Targeted Therapy Abemaciclib (Verzenio)
Clinicaltrials.gov identifier:
NCT05372640
Treatment
Phase 1 treatment study for advanced breast cancer and other solid tumors
Phase 1
Study of a New Investigational Inhibitor to Treat People with Advanced Solid Tumors
Clinicaltrials.gov identifier:
NCT05932862
Treatment
Treatment study for people with advanced solid tumors
Phase 1